2024 annual financial data
Structure Therapeutics 2024 Operating margin
Structure Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -158,228,000 USD and net income was -122,526,000 USD.
Operating cash flow was -116,636,000 USD.
Get free Structure Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -158,228,000 USD
- Net income
- -122,526,000 USD
- Operating cash flow
- -116,636,000 USD